Compliance with Australian Orthopaedic Association guidelines does not reduce the risk of venous thromboembolism after total hip and knee arthroplasty.
Clinical guidelines
Primary total hip arthroplasty
Primary total knee arthroplasty
Prophylaxis
Surgical complications
Venous thromboembolism
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
12 Mar 2024
12 Mar 2024
Historique:
received:
03
04
2022
accepted:
18
02
2024
medline:
12
3
2024
pubmed:
12
3
2024
entrez:
12
3
2024
Statut:
epublish
Résumé
Preventing avoidable venous-thrombo-embolism (VTE) is a priority to improve patient and service outcomes after total hip and total knee arthroplasty (THA, TKA), but compliance with relevant clinical guidelines varies. This study aims to determine the degree to which prophylaxis was compliant with Australian Orthopaedic Association (AOA) VTE prophylaxis guidelines and whether non-compliance is associated with increased risk of VTE. A prospective multi-centre cohort study of adults with osteoarthritis undergoing primary TKA/THA was completed at 19 high-volume public and private hospitals. Data were collected prior to surgery and for one-year post-surgery. Logistic regression was undertaken to explore associations between non-compliance with AOA VTE prophylaxis guidelines and symptomatic 90-day VTE outcomes. Data were analysed for 1838 participants from 19 sites. The rate of non-compliance with all clinical guideline recommendations was 20.1% (N = 369), with 14.1% (N = 259) non-compliance for risk-stratified prophylaxis, 35.8% (N = 658) for duration, and 67.8% (N = 1246) for other general recommendations. Symptomatic VTE was experienced up to 90-days post-surgery by 48 people (2.6%). Overall guideline non-compliance (AOR = 0.93, 95%CI = 0.4 to 1.3, p = 0.86) was not associated with a lower risk of symptomatic 90-day VTE. Results were consistent when people with high bleeding risk were excluded (AOR = 0.94, 95%CI = 0.44 to 2.34, p = 0.89). Non-compliance with the AOA VTE prophylaxis guidelines was not associated with risk of 90-day VTE after arthroplasty. This counterintuitive finding is concerning and necessitates a rigorous review of the AOA VTE prevention clinical guideline.
Identifiants
pubmed: 38467650
doi: 10.1038/s41598-024-54916-x
pii: 10.1038/s41598-024-54916-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5955Informations de copyright
© 2024. The Author(s).
Références
Kahn, S. R. & Shivakumar, S. What’s new in VTE risk and prevention in orthopedic surgery. Res. Pract. Thromb. Haemost. 4, 366–376. https://doi.org/10.1002/rth2.12323 (2020).
doi: 10.1002/rth2.12323
pubmed: 32211571
pmcid: 7086463
Gao, J. H., Chu, X. C., Wang, L. L., Ning, B. & Zhao, C. X. Effects of different anticoagulant drugs on the prevention of complications in patients after arthroplasty: A network meta-analysis. Medicine 96, e8059. https://doi.org/10.1097/md.0000000000008059 (2017).
doi: 10.1097/md.0000000000008059
pubmed: 28984761
pmcid: 5737997
Suen, K., Westh, R. N., Churilov, L. & Hardidge, A. J. Low-molecular-weight heparin and the relative risk of surgical site bleeding complications: Results of a systematic review and meta-analysis of randomized controlled trials of venous thromboprophylaxis in patients after total joint arthroplasty. J. Arthroplast. 32, 2911-2919.e2916. https://doi.org/10.1016/j.arth.2017.04.010 (2017).
doi: 10.1016/j.arth.2017.04.010
Farfan, M. et al. Worldwide adherence to ACCP guidelines for thromboprophylaxis after major orthopedic surgery: A systematic review of the literature and meta-analysis. Thromb. Res. 141, 163–170. https://doi.org/10.1016/j.thromres.2016.03.029 (2016).
doi: 10.1016/j.thromres.2016.03.029
pubmed: 27058273
AOA Arthroplasty Society of Australia. Guidelines for VTE prophylaxis for hip and knee arthroplasty. https://arthroplasty.org.au/wp-content/uploads/2024/01/asa-guidelines-for-vte-prophylaxis-for-hip-and-knee-arthroplasty-february-2018.pdf (2018).
Mirkazemi, C., Bereznicki, L. R. & Peterson, G. M. Comparing Australian orthopaedic surgeons’ reported use of thromboprophylaxis following arthroplasty in 2012 and 2017. BMC Musculoskelet. Disord. 20, 57–57. https://doi.org/10.1186/s12891-019-2409-3 (2019).
doi: 10.1186/s12891-019-2409-3
pubmed: 30736774
pmcid: 6368726
National Health and Medical Research Council. Clinical practice guideline for the prevention of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to Australian hospitals (National Health and Medical Research Council, Melbourne, 2009).
Sabharwal, S., Patel, N. K., Gauher, S., Holloway, I. & Athansiou, T. High methodologic quality but poor applicability: assessment of the AAOS guidelines using the AGREE II instrument. Clin. Orthop. Relat. Res. 472, 1982–1988. https://doi.org/10.1007/s11999-014-3530-0 (2014).
doi: 10.1007/s11999-014-3530-0
pubmed: 24566890
pmcid: 4016437
Sabharwal, S. et al. Quality assessment of guidelines on thromboprophylaxis in orthopaedic surgery. Bone Joint J. 96, 19–23. https://doi.org/10.1302/0301-620X.96B1.32943 (2014).
doi: 10.1302/0301-620X.96B1.32943
pubmed: 24395305
Clinicaltrials.gov [Internet]. Clinical trial registration, < https://www.clinicaltrials.gov/ct2/show/NCT01899443?term=Improving+Services+and+Outcomes+for+Joint+Replacement+Patients&draw=2&rank=1 > (2013).
Von Elm, E. et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. PLoS Med. 4, e296. https://doi.org/10.1371/journal.pmed.0040296 (2007).
doi: 10.1371/journal.pmed.0040296
R: A language and environment for statistical computing (R Foundation for Statistical Computing, Vienna, Austria, 2019).
Vanderbilt University. Research Electronic Data Capture (REDCap). Version 5.12.2 https://projectredcap.org/ (Vanderbilt University, 2017).
Altom, L. K. et al. Association between Surgical Care Improvement Program venous thromboembolism measures and postoperative events. Am. J. Surg. 204, 591–597 (2012).
doi: 10.1016/j.amjsurg.2012.07.006
pubmed: 22906249
Chang, V. et al. Discordance between surgical care improvement project adherence and postoperative outcomes: Implications for new Joint Commission standards. J. Surg. Res. 212, 205–213. https://doi.org/10.1016/j.jss.2017.01.006 (2017).
doi: 10.1016/j.jss.2017.01.006
pubmed: 28550908
Lau, B. D., Streiff, M. B., Pronovost, P. J. & Haut, E. R. Venous thromboembolism quality measures fail to accurately measure quality. Circulation 137, 1278–1284. https://doi.org/10.1161/CIRCULATIONAHA.116.026897 (2018).
doi: 10.1161/CIRCULATIONAHA.116.026897
pubmed: 29555709
Badge, H. M. et al. Non-compliance with clinical guidelines increases the risk of complications after primary total hip and knee joint replacement surgery. PloS one 16, e0260146. https://doi.org/10.1371/journal.pone.0260146 (2021).
doi: 10.1371/journal.pone.0260146
pubmed: 34793555
pmcid: 8601457
Farey, J. E., An, V. V. G., Sidhu, V., Karunaratne, S. & Harris, I. A. Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: A systematic review and meta-analysis. Orthop. Traumatol. Surg. Res. https://doi.org/10.1016/j.otsr.2020.04.002 (2020).
doi: 10.1016/j.otsr.2020.04.002
pubmed: 32631716
Matharu, G. S., Kunutsor, S. K., Judge, A., Blom, A. W. & Whitehouse, M. R. Clinical effectiveness and safety of aspirin for venous thromboembolism prophylaxis after total hip and knee replacement: A systematic review and meta-analysis of randomized clinical trials. JAMA Intern. Med. 180, 376–384. https://doi.org/10.1001/jamainternmed.2019.6108 (2020).
doi: 10.1001/jamainternmed.2019.6108
pubmed: 32011647
pmcid: 7042877
Khalid, A. et al. Efficacy and safety of thromboprophylaxis Ppst-orthopedic srgery. Cureus https://doi.org/10.7759/cureus.19691 (2021).
doi: 10.7759/cureus.19691
pubmed: 35047312
pmcid: 8760027
Smith, S. R., Katz, J. N. & Losina, E. Cost-effectiveness of alternative anticoagulation strategies for postoperative management of total knee arthroplasty patients. Arthritis Care Res. 71, 1621–1629. https://doi.org/10.1002/acr.23803 (2019).
doi: 10.1002/acr.23803
Le, G. et al. Efficacy and safety of aspirin and rivaroxaban for venous thromboembolism prophylaxis after total hip or knee arthroplasty: A protocol for meta-analysis. Medicine 99, e23055 (2020).
doi: 10.1097/MD.0000000000023055
pubmed: 33285683
pmcid: 7717737
Wilson, D. G. G., Poole, W. E. C., Chauhan, S. K. & Rogers, B. A. Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty. Bone Joint J. 98-B, 1056–1061. https://doi.org/10.1302/0301-620x.98b8.36957 (2016).
doi: 10.1302/0301-620x.98b8.36957
pubmed: 27482017
Trivedi, N. N., Fitzgerald, S. J., Schmaier, A. H. & Wera, G. D. Venous thromboembolism chemoprophylaxis in total hip and knee arthroplasty. JBJS Rev. 7, e2. https://doi.org/10.2106/jbjs.rvw.18.00010 (2019).
doi: 10.2106/jbjs.rvw.18.00010
pubmed: 30601202
Nemeth, B., Nelissen, R., Arya, R. & Cannegieter, S. Preventing VTE following total hip and knee arthroplasty: Is prediction the future?. J. Thromb. Haemost. 19, 41–45. https://doi.org/10.1111/jth.15132 (2021).
doi: 10.1111/jth.15132
pubmed: 33043553
Nicholson, M., Chan, N., Bhagirath, V. & Ginsberg, J. Prevention of venous thromboembolism in 2020 and beyond. J. Clin. Med. 9, 2467. https://doi.org/10.3390/jcm9082467 (2020).
doi: 10.3390/jcm9082467
pubmed: 32752154
pmcid: 7465935
Torrejon Torres, R., Saunders, R. & Ho, K. M. A comparative cost-effectiveness analysis of mechanical and pharmacological VTE prophylaxis after lower limb arthroplasty in Australia. J. Orthop. Surg. Res. https://doi.org/10.1186/s13018-019-1124-y (2019).
doi: 10.1186/s13018-019-1124-y
pubmed: 30940168
pmcid: 6444865
Henke, P. K. et al. Call to action to prevent venous thromboembolism in hospitalized patients: A policy statement from the American Heart Association. Circulation 141, e914–e931. https://doi.org/10.1161/CIR.0000000000000769 (2020).
doi: 10.1161/CIR.0000000000000769
pubmed: 32375490
Wang, Y. et al. Quality appraisal of clinical guidelines for venous thromboembolism prophylaxis in patients undergoing hip and knee arthroplasty: A systematic review. BMJ Open 10, e040686–e040686. https://doi.org/10.1136/bmjopen-2020-040686 (2020).
doi: 10.1136/bmjopen-2020-040686
pubmed: 33303451
pmcid: 7733196
Amin, A. et al. Appropriate VTE prophylaxis is associated with lower direct medical costs. Hosp. Prac. 38, 130–137. https://doi.org/10.3810/hp.2010.11.350 (2010).
doi: 10.3810/hp.2010.11.350
Kredo, T. et al. Guide to clinical practice guidelines: The current state of play. Int. J. Qual. Health Care 28, 122–128. https://doi.org/10.1093/intqhc/mzv115 (2016).
doi: 10.1093/intqhc/mzv115
pubmed: 26796486
pmcid: 4767049
National Health and Medical Research Council. Procedures and requirements for meeting the 2011 NHMRC standard for clinical practice guidelines: Summary for developers. https://www.nhmrc.gov.au/about-us/publications/meeting-2011-nhmrc-standard-clinical-practice-guidelines (Melbourne, 2011).
Oxman, A. D., Fretheim, A. & Schünemann, H. J. Improving the use of research evidence in guideline development: Introduction. Health Res. Policy Syst. 4, 12. https://doi.org/10.1186/1478-4505-4-14 (2006).
doi: 10.1186/1478-4505-4-12
pubmed: 17116254
pmcid: 1684247
Peel, T. N. et al. Direct hospital cost determinants following hip and knee arthroplasty. Arthritis Care Res. 67, 782–790. https://doi.org/10.1002/acr.22523 (2015).
doi: 10.1002/acr.22523